 Subjects with house dust mite allergic asthma were randomised to receive either SLITone Dermatophagoides mix active or placebo treatment 1:1 for approximately 1 year. The trial duration was extended to 2 years. Administration was done sublingually under the tongue once daily preferably in the morning. A monodose container comprised the daily dose of 200 STU. 